Glutamate oxaloacetate transaminase 2 (GOT2) has been repeatedly reported in recent years to be associated with the progression of pancreatic cancer,47, 48 but its role in HCC remains unclear. Here, GOT2 is linked to familial pancreatic carcinoma.